Silencing of nucleolin expression by siRNAs and AS1411 suppressed midkine-induced EGFR signaling and PASMC proliferation, and this inhibitor was shown to attenuate the development of PAH by suppressing pulmonary arterial remodeling. The gene discussed is NUCLEOLIN; the disease is pulmonary arterial hypertension.